Fish, Laura J., Bercedis L. Peterson, Rebecca J. Namenek Brouwer, Pauline Lyna, Cheryl A. Oncken, Geeta K. Swamy, Evan R. Myers, Pamela K. Pletsch, and Kathryn I. Pollak. “Adherence to nicotine replacement therapy among pregnant smokers..” Nicotine Tob Res 11, no. 5 (May 2009): 514–18. https://doi.org/10.1093/ntr/ntp032.
Geeta Krishna Swamy, MD
Dr. Geeta Swamy, MD, became Vice Chair for Research and Faculty Development in the Department of Obstetrics and Gynecology on March 1, 2018. In this dual role, Dr. Swamy oversees strategic development and administration of the Department’s basic, translational and clinical research programs, as well as implements and oversees programs to support development and mentorship for all faculty at all levels.
Dr. Swamy has dedicated her career to advancing research in women’s health and to mentoring faculty and trainees. She is an internationally recognized clinician-researcher, and an expert and nationally-recognized leader in the field of maternal immunization and vaccination in pregnancy. Her research has been funded by the National Institutes of Health (NIH), Centers for Disease Control (CDC), Environmental Protection Agency (EPA) and others. She currently serves as the Co-Principal Investigator for the NIH-NIAID Vaccine Treatment and Evaluation (VTEU) and CDC-funded Clinical Immunization Safety Assessment, and has published over 100 peer-reviewed manuscripts. Dr. Swamy has been the Director of the Duke Perinatal Research Center since 2010.
Dr. Swamy has also been instrumental in developing and leading the School of Medicine’s Research Regulatory and Compliance initiatives, first as Chair of the IRB and then as Associate Dean for Clinical Research for Regulatory Oversight and Research Initiatives. This past fall, she was promoted to Senior Associate Dean for Clinical Research in the School of Medicine.
Dr. Swamy's focused area of interests are perinatal infection, maternal immunization and preterm birth.
Education and Training
- Resident, Obstetrics And Gynecology, University of Pittsburgh, 1997 - 2001
- M.D., University of North Carolina at Chapel Hill, 1997
Selected Grants and Awards
- Population Health Research Support IDIQ Base
- VTEU A-1 Admin
- Duke CTSA (KL2)
- Duke CTSA (TL1)
- CISA 2018-2019- Clinical Consult - Opt 1
- RTOP 2018 CISA 01 Flublok Lead Base
- RTOP 2018 CISA 01 Flublok Lead Task 1
- Pulmonary Complications in a Brith Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study Capitation
- VTEU Task Order 18-0011.B1.C1.0116-Task C Option 1
- NICHD Maternal Fetal Medicine Units Network
- Eunice Kennedy Shriver NICHD Cooperative Multicenter Neonatal Research Network
- RSV- M-301
- The relationship between maternal ZIKV-specific and ADE antibodies and fetal outcome
- VTEU Task Area C Option 2-3 Protocol 15-0020.B1C1.0040
- VTEU Task Area C Option 2-2 Protocol 15-0020.B1C1.0040
- Pulmonary Complications in a Brith Cohort after a Randomized Trial of Exposure to Antenatal Corticosteroids: the ALPS Follow-Up Study
- VTEU RTOP FY.2019.A1B1C1D1.0103 - Task A - Base
- Rapid, Near Patient Nucleic Acid Testing for Infant Cytomegalovirus (CMV) Infection
- UNC-Duke Collaborative Clinical Pharmacology Postdoctoral Training Program
- MFMU Network Studies
- CISA: 2015 CISA 03 - Lead Site Base Task: Maternal Tdap and IIV Study (Lead)
- Duke Research Training Program for Pediatricians
- Duke CTSA (UL1)
- CISA Task Order No. 3 Tdap Safety in Pregnant Women
- DMID 05-0048 Tdap Vaccine in Pregnant Women
- DMID 09-0005 Safety and Immunogenicity
- Effectiveness of a Vaccination Program in the Community ObGyn Setting
- 09-0056 A Phase II Study in Pregnant Women to Assess H1N1 Vaccine
- A randomized double-blind trial on the safety and immunogenicity of inactivated trivalent influenza vaccine in pregnant
- PiiiTCH Study
Østbye, Truls, Katrina M. Krause, Rebecca J. N. Brouwer, Cheryl A. Lovelady, Miriam C. Morey, Lori A. Bastian, Bercedis L. Peterson, Geeta K. Swamy, Jaspreet Chowdhary, and Colleen M. McBride. “Active Mothers Postpartum (AMP): rationale, design, and baseline characteristics..” J Womens Health (Larchmt) 17, no. 10 (December 2008): 1567–75. https://doi.org/10.1089/jwh.2007.0674.
Swamy, G. K. “Association of preterm birth with long-term survival, reproduction, and next-generation preterm birth - (vol 299, pg 1429, 2008).” Jama Journal of the American Medical Association 300, no. 2 (July 9, 2008): 170–71.
Swamy, G. K., S. Edwards, A. Gelfand, and M. L. Miranda. “Maternal age, birth order, and race: Differential effects on birthweight.” In American Journal of Epidemiology, 167:S22–S22. OXFORD UNIV PRESS INC, 2008.
Myers, Evan R., Douglas C. McCrory, Alyssa A. Mills, Thomas M. Price, Geeta K. Swamy, Julierut Tantibhedhyangkul, Jennifer M. Wu, and David B. Matchar. “Effectiveness of assisted reproductive technology (ART)..” Evid Rep Technol Assess (Full Rep), no. 167 (May 2008): 1–195.
Canzoneri, Bernard J., Chad A. Grotegut, Geeta K. Swamy, Leo R. Brancazio, and Amy P. Murtha. “Antibiotics appear to suppress maternal serum interleukin-6 levels in women with preterm premature rupture of membranes.” In Reproductive Sciences, 15:185A-186A. SAGE PUBLICATIONS INC, 2008.
Kaiser, Lisa M., Marie Lynn Miranda, Jon Hussey, Paul Buescher, Dohyeong Kim, and Geeta K. Swamy. “Association of adequacy of prenatal care utilization and maternal health status with birth outcomes in North Carolina, 1999-2003..” In Reproductive Sciences, 15:251A-251A. SAGE PUBLICATIONS INC, 2008.